Viventia biotechnologies inc. – product pipeline review – 2012


Published on

2012 || Viventia Biotechnologies Inc. – Product Pipeline Review – 2012

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Viventia biotechnologies inc. – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Viventia Biotechnologies Inc. – Product Pipeline Review –2012 link of Global Markets Direct Market Direct’s pharmaceuticals report, “Viventia Biotechnologies Inc. -Product Pipeline Review - 2012” provides data on the Viventia BiotechnologiesInc.’s research and development focus. The report includes information on currentdevelopmental pipeline, complete with latest updates, and features on discontinuedand dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Viventia Biotechnologies Inc.’s corporate website, SEC filings,investor presentations and featured press releases, both from ViventiaBiotechnologies Inc. and industry-specific third party sources, put together byGlobal Markets Direct’s team.Scope- Viventia Biotechnologies Inc. - Brief Viventia Biotechnologies Inc. overviewincluding business description, key information and facts, and its locations andsubsidiaries.- Review of current pipeline of Viventia Biotechnologies Inc. human therapeuticdivision.
  2. 2. - Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Table of contents:List of Tables 4List of Figures 4Viventia Biotechnologies Inc. Snapshot 5Viventia Biotechnologies Inc. Overview 5Key Information 5Key Facts 5Viventia Biotechnologies Inc. – Research and Development Overview 6Key Therapeutic Areas 6Viventia Biotechnologies Inc. – Pipeline Review 9Pipeline Products by Stage of Development 9Pipeline Products – Monotherapy 10Viventia Biotechnologies Inc. – Pipeline Products Glance 11Viventia Biotechnologies Inc. Clinical Stage Pipeline Products 11Phase II Products/Combination Treatment Modalities 11Phase I Products/Combination Treatment Modalities 12Viventia Biotechnologies Inc. – Early Stage Pipeline Products 13Pre-Clinical Products/Combination Treatment Modalities 13Viventia Biotechnologies Inc. – Drug Profiles 14VB6-008 14Product Description 14Mechanism of Action 14R&D Progress 14VB6-011 15Product Description 15Mechanism of Action 15R&D Progress 15VB6-050 16Product Description 16Mechanism of Action 16R&D Progress 16VB6-845 17
  3. 3. Product Description 17Mechanism of Action 17R&D Progress 17Vicinium 18List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview&PubId=&pagenum=1United Therapeutics Corporation – Product Pipeline Review – 2012Vaxon Biotech – Product Pipeline Review – 2012Versartis, Inc. – Product Pipeline Review – 2012ViroStatics, srl – Product Pipeline Review – 2012Viventia Biotechnologies Inc. – Product Pipeline Review – 2012Xencor, Inc. – Product Pipeline Review – 2012Xention Limited – Product Pipeline Review – 2012
  4. 4. 4-Antibody AG – Product Pipeline Review – 2012Archer Biosciences, Inc – Product Pipeline Review – 2012Bio-Link – Product Pipeline Review – 2012SWITCH Biotech LLC – Product Pipeline Review – 2012Teikoku Pharma USA, Inc. – Product Pipeline Review – 2012TetraLogic Pharmaceuticals – Product Pipeline Review – 2012Tranzyme Pharma, Inc. – Product Pipeline Review – 2012Unigene Laboratories, Inc. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports
  5. 5. For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: